Our People: Healthcare & Biotechnology
Tim Dainton – Equity Sales
Tim joined KBC Peel Hunt in 2003 as a specialist salesman in the technology and biotech sectors.
He has 15 year‘s experience as a mid and small cap fund manager, and has worked for Gartmore and Aetna Investment Management as a fund manager specialising in the financial and real estate sectors. Tim was a financial and property specialist in his early days at Aetna. He later moved onto smaller companies, joined Gartmore as a small cap specialist before moving to KBC Peel Hunt.
tim.dainton@kbcpeelhunt.com
Dr. Ceri Morgan – Equity Sales
Dr Ceri Morgan joined KBC Peel Hunt in 2007 as a specialist salesperson in the healthcare and biotech sectors.
Ceri read medicine and has worked in casualty and trauma, respiratory and renal medicine before specialising in general medicine and cardiology. She is a former healthcare analyst for Evolution Group. Over the past three years she has worked as an independent advisor to IP Group specialising in their healthcare spin outs.
ceri.morgan@kbcpeelhunt.com
Capel Irwin – Director, Corporate Finance
Capel joined KBC Peel Hunt in 1995, and has 14 years’ capital markets experience, providing Corporate Finance advice in the small and mid cap sector, including flotations, takeovers, restructuring, acquisitions and disposals.
Capel is an Economics graduate and started his career as a corporate solicitor.
capel.irwin@kbcpeelhunt.com
David Anderson – Corporate Finance
David joined KBC Peel Hunt in 2003 where he has had an equal focus on mergers & acquisitions and capital markets providing advice to mid and small cap Official List and AIM clients.
David graduated with an honours degree in geography from the University of Bristol in 2000. He joined UBS Warburg (now UBS) a year later working in the Mid Market Group of the Investment Banking Division for two years where he transacted a number of mid cap acquisitions, fundraisings and restructurings.
david.anderson@kbcpeelhunt.com
Dr. Shelley Cook – Biotechnology Consultant
Dr Shelley Cook MA MSc DPhil is KBC Peel Hunt’s Consultant in Biotechnology. Shelley is currently setting up an Emerging Virus Unit at the Natural History Museum, in collaboration with UK and US Government advisors on epidemic threats. Shelley has a DPhil from Oxford University and prior to joining KBC Peel Hunt in 2005, she worked as a Consultant to the Pharmaceutical industry.
shelley.cook@kbcpeelhunt.com
Paul Cuddon – Analyst
Paul joined KBC Peel Hunt in 2007 following 6 years developing therapies for diseases of the nervous system. After graduating from Birmingham University, Paul completed his PhD at Cambridge, working on the mechanisms underlying stroke.
paul.cuddon@kbcpeelhunt.com
